tyrosine has been researched along with benazepril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, JE; Chatelain, R; Fink, CA; Jeng, AY; McTaggart, PA; Qiao, Y; Trapani, AJ; Webb, R | 1 |
| Cohen, DS; Dotson, RA; Graybill, SR; Mathis, JE; Wosu, NJ | 1 |
2 other study(ies) available for tyrosine and benazepril
| Article | Year |
|---|---|
Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Captopril; Dipeptides; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Neprilysin; Protease Inhibitors; Rats; Rats, Inbred SHR; Tyrosine | 1996 |
Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Creatinine; Cyclic GMP; Electrolytes; Kidney; Kidney Failure, Chronic; Male; Nephrectomy; Neprilysin; Protease Inhibitors; Proteinuria; Rats; Rats, Sprague-Dawley; Tyrosine | 1998 |